The global pain medication market reached US $ 74 billion in 2020. Pain is a distressing feeling that can be caused by various health issues such as osteoarthritis, chronic arthritis, diabetic neuropathy, sclerosis in plaques and cancer. The mechanism of pain is a complex process, and there are several pain management drugs that provide relief by working through various physiological functions. These drugs are specific drugs which exert pharmacological actions on pain receptors and act against symptoms causing discomfort.

Market breakdown by drug class:

• NSAIDs
• Anesthetics
• Anticonvulsants
• Anti-migraine agents
• Antidepressants
• Opioids
• Others

Request a copy of a sample report: https://www.imarcgroup.com/pain-management-drugs-market/requestsample

The high prevalence of chronic painful diseases and the increase in the geriatric population are among the key factors. With the prevalence of chronic pain being significantly higher in the elderly, this is a key factor driving the demand for pain management medications. In addition, the increasing number of hospitalization cases, the huge gap between the supply and demand of effective drugs for the management of neuropathic pain and the application of innovative and advanced therapies are also catalyzing the market growth. Looking ahead, the market is expected to show moderate growth during 2021-2026.

Mountain peak CoPain Management Drugs Companies Industry:

• Abbott Laboratories
• Pfizer
• Eli Lilly & Company
• Endo International plc
• Hoffmann-La Roche SA
• Bausch healthcare companies
• Merck
• Allergen
• Novartis International SA
• Johnson & johnson
• GlaxoSmithKline Plc
• Purdue Pharma LP

Note – We are updating our reports. If you want the latest primary and secondary data (2021-2026) with cost module, business strategy, distribution channel etc. Click request free sample report, the published report will be delivered to you in PDF format via email within 24-48 hours.

About Us:

The IMARC group is a leading market research company providing management strategies and market research worldwide. We partner with clients across industries and regions to identify their most exciting opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include key business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasting and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and new processing methods are at the top of the market. business expertise.

Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com
Email: [email protected]
United States: + 1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Associated reports: